By Targeted Oncology Staff February 4th 2025 New Insights into the Links Between Heart Disease and Breast Cancer By Amy M. Ahnert, MD February 3rd 2025 Video Series Considering Elacestrant in ESR1+ Breast Cancer After CDK4/6 Inhibition Sequencing and AEs Guide Next Steps for Dato-DXd in Brea...
The first sign of breast cancer often is a breast lump or an abnormal mammogram. Breast cancer stages range from early, curable breast cancer to metastatic breast cancer, with a variety of breast cancer treatments. Male breast cancer is not uncommon and
Cancer Horizons Clinical Trial Corner Heal® Publications Videos > All Subspecialties CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and ...
Discussing, Managing, and Treating HER2+ Breast Cancer From the Patient’s Perspective ONCOLOGY Staff December 30th 2024 In a From All Angles program, a patient and her treating physician spoke about the initial diagnosis, care coordination, communication, and the adverse effects observed. ...
First-Line Camizestrant Plus CDK4/6 Inhibition Boosts PFS in ERS1+, HR+/HER2-Negative Advanced Breast Cancer By Kyle Doherty February 27th 2025 Cardio-Oncology Investigations Begin to Uncover More Links Between CVD and Breast Cancer By Megan Hollasch February 26th 2025 HyperVIEW X-Ray System ...
Breast cancer in men (BCiM) is a very rare disease that is still understudied and most of the published data comes from small cohorts of patients, compared to breast cancer in women. Genetic factors are among the most clearly established risk factors for male breast cancer, and mainly involve...
《乳腺癌》(Breast Cancer)是一本以ONCOLOGY-OBSTETRICS & GYNECOLOGY综合研究为特色的国际期刊。该刊由Springer Japan出版商创刊于1994年,刊期6 issues per year。该刊已被国际重要权威数据库SCIE收录。期刊聚焦ONCOLOGY-OBSTETRICS & GYNECOLOGY领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于成为该领域...
When cells in the breast begin to grow out of control due to changes in DNA, breast cancer can begin. Often from a tumor, these cells may be visible on imaging or felt as a lump in the breast. If the cells invade other tissues or spread to distant parts of the body, the tumor wou...
Explore the benefits of the genomic Oncotype DX® tests for breast cancer—the Breast Recurrence Score® test and the Breast DCIS (ductal carcinoma in situ) Score® test.
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D 1.从收到稿件到接受稿件用时:1.4个月 A nested case-control study on radiationdose-responsefor cardiac events in breast cancer patients in Germany ...